Abbott Laboratories Stock Performance
| ABT Stock | USD 107.07 0.21 0.20% |
The firm shows a Beta (market volatility) of 0.91, which signifies possible diversification benefits within a given portfolio. Abbott Laboratories returns are very sensitive to returns on the market. As the market goes up or down, Abbott Laboratories is expected to follow. Abbott Laboratories has an expected return of -0.0398%. Please make sure to confirm Abbott Laboratories standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Abbott Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Abbott Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return 0.69 | Five Day Return 1.23 | Year To Date Return (1.86) | Ten Year Return 179.3 | All Time Return 65.4 K |
Forward Dividend Yield 0.0205 | Payout Ratio 0.3911 | Last Split Factor 10000:4798 | Forward Dividend Rate 2.2 | Dividend Date 2024-05-15 |
| Abbott Laboratories dividend paid on 15th of February 2024 | 02/15/2024 |
1 | 25 Countries with the Highest Death Rate From Malnutrition | 03/26/2024 |
2 | FDA approves Abbott TriClip TEER system | 04/02/2024 |
3 | Ahead of Abbott Q1 Earnings Get Ready With Wall Street Estimates for Key Metrics | 04/12/2024 |
4 | FDA announces recall of heart pumps linked to deaths and injuries | 04/16/2024 |
5 | Abbott Laboratories Q1 2024 Earnings Call Transcript | 04/17/2024 |
6 | Citi maintains stock target on Abbott Labs with Buy rating on strong Q1 performance | 04/18/2024 |
7 | Should You Expect Accelerating Earnings Growth for Abbott Laboratories | 04/19/2024 |
8 | Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and m... | 04/22/2024 |
| Begin Period Cash Flow | 9.9 B |
Abbott |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 11,022 in Abbott Laboratories on January 24, 2024 and sell it today you would lose (315.00) from holding Abbott Laboratories or give up 2.86% of portfolio value over 90 days. Abbott Laboratories is generating negative expected returns assuming volatility of 1.186% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Abbott, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Abbott Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbott Laboratories, and traders can use it to determine the average amount a Abbott Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0336
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABT |
Estimated Market Risk
| 1.19 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abbott Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbott Laboratories by adding Abbott Laboratories to a well-diversified portfolio.
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0611 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 194.6 B | ||||
| Shares Outstanding | 1.74 B | ||||
| Price To Earning | 24.14 X | ||||
| Price To Book | 4.90 X | ||||
| Price To Sales | 4.72 X | ||||
| Revenue | 40.11 B | ||||
| Gross Profit | 24.58 B | ||||
| EBITDA | 10.59 B | ||||
| Net Income | 5.7 B | ||||
| Cash And Equivalents | 9.88 B | ||||
| Cash Per Share | 5.68 X | ||||
| Total Debt | 15.87 B | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | 22.26 X | ||||
| Cash Flow From Operations | 7.26 B | ||||
| Earnings Per Share | 3.21 X | ||||
| Market Capitalization | 185.79 B | ||||
| Total Asset | 73.21 B | ||||
| Retained Earnings | 37.55 B | ||||
| Working Capital | 8.83 B | ||||
| Current Asset | 14.15 B | ||||
| Current Liabilities | 9.19 B | ||||
About Abbott Laboratories Performance
To evaluate Abbott Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abbott Laboratories generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abbott Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abbott Laboratories market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Abbott's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 133.41 | 81.82 | |
| Return On Tangible Assets | 0.14 | 0.17 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.08 | 0.12 | |
| Return On Equity | 0.15 | 0.26 |
Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Abbott Laboratories has a strong financial position based on the latest SEC filings | |
| Over 77.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from prnewswire.com: Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio |
- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.